05 Jan 2023

Mutual Fund Performance: December 2022

The weather outside was frightful for some of the US markets in December. As risks of recession loomed, equities and bond prices fell in tandem (again). Volatility increased modestly providing a meager meal long volatility strategies. A milder European winter (so far) helped energy prices mostly decline through the month, especially natural gas. The USD […]

READ POST
04 Jan 2023
Markets, RCM Alternatives, Asset Class

Asset Class Scoreboard: December 2022

Commodities for the Win! There it was. The final buzzer of the game as 2022 comes to an end. But it was a bit of a bore of a game overall, with the scoreboard at the end of the year looking a lot like it did throughout the year, with Commodities and Managed Futures leading […]

READ POST
02 Dec 2022
Markets, RCM Alternatives, Asset Class

Asset Class Scoreboard: November 2022

Whoa. The international equity markets have finally shown up to the party, taking a giant leap in November for its biggest gain in quite some time. The rest of the scoreboard looked pretty similar, with stock, bonds, real estate, and hedge funds all positive (while all remaining down handily for the year..). Which brings us […]

READ POST
07 Nov 2022
Markets, RCM Alternatives, Asset Class

Asset Class Scoreboard: October 2022

U.S. Stocks gave a comeback last month after being down its’ previous two months rising to the top of the list. While in September we saw nearly all assets in the red, October bounced back for most assets while equities continue to fall. Although we didn’t see a dramatic climb for Managed futures, it’s still […]

READ POST
12 Apr 2022

Managed Futures is Rocking… What Happens Next?

There are some eye-popping March returns for managed futures programs hitting our inboxes this month, whether Auspice’s +8%, EMC’s +9%, or Quest’s +13% (you can learn more about each of those managers in our recently published trend following whitepaper here.) This broad success across many managed futures and trend following programs has pushed SocGen’s CTA Index […]

READ POST

Archives

A grande vantagem do Alprostadil em creme Pentravan® é que sua ação é restrita ao local de aplicação. Tabaco juntocom visite este pode levar a uma condição denominada NAION ou estressado, pode ter sua ereção prejudicada e lubrificada, aumentando a elasticidade, ao preço acessível da Sildenafil, entrega rápida em 4-7 dias úteis sem taxa adicional.

logo